Ursodeoxycholic acid is associated with improved long-term outcome in patients with primary sclerosing cholangitis

被引：0
|
作者：
Toshihiko Arizumi
Susumu Tazuma
Hiroyuki Isayama
Takahiro Nakazawa
Toshio Tsuyuguchi
Hajime Takikawa
Atsushi Tanaka
机构：
[1] Teikyo University School of Medicine,Department of Medicine
[2] Hiroshima University,Department of General Internal Medicine, Graduate School of Biomedical & Health Sciences
[3] Juntendo University,Department of Gastroenterology, Graduate School of Medicine
[4] Nagoya City University,Department of Gastroenterology
[5] Chiba University,Department of Medicine and Clinical Oncology, Graduate School of Medicine
[6] Teikyo University,Faculty of Medical Technology
来源：
Journal of Gastroenterology | 2022年 / 57卷
关键词：
Ursodeoxycholic acid; Long-term outcomes; Primary sclerosing cholangitis; Liver transplantation-free survival;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：902 / 912
页数：10
相关论文
共 50 条
  • [21] Chernopreventive effect of ursodeoxycholic acid in primary sclerosing cholangitis?
    Brandsæter, B
    Isoniemi, H
    Broomé, U
    Olausson, M
    Bäckman, L
    Hansen, B
    Oksanen, A
    Ericzon, BG
    Höckerstedt, K
    Mäkisalo, H
    Kirkegaard, P
    Friman, S
    Bjoro, K
    Schrumpf, E
    Bile Acid Biology and Its Therapeutic Implications, 2005, 141 : 242 - 249
  • [22] ASYMPTOMATIC PRIMARY SCLEROSING CHOLANGITIS TREATED WITH URSODEOXYCHOLIC ACID
    HAYASHI, H
    HIGUCHI, T
    ICHIMIYA, H
    HISHIDA, N
    SAKAMOTO, N
    GASTROENTEROLOGY, 1990, 99 (02) : 533 - 535
  • [23] Medical treatment of primary sclerosing cholangitis with ursodeoxycholic acid
    Chapman, RW
    DIGESTIVE AND LIVER DISEASE, 2003, 35 (05) : 306 - 308
  • [24] LONG-TERM EVOLUTION OF PEDIATRIC AUTOIMMUNE CHOLANGITIS AND PRIMARY SCLEROSING CHOLANGITIS
    Willems, Philippe
    Hercun, Julian
    Vincent, Catherine
    Alvarez, Fernando
    HEPATOLOGY, 2020, 72 : 753A - 753A
  • [25] Prevalence and long-term outcome of sub-clinical primary sclerosing cholangitis in patients with ulcerative colitis
    Culver, Emma L.
    Bungay, Helen K.
    Betts, Margaret
    Forde, Colm
    Buchel, Otto
    Manganis, Charis
    Warren, Bryan F.
    Cummings, Fraser R.
    Keshav, Satish
    Travis, Simon P. L.
    Chapman, Roger W.
    LIVER INTERNATIONAL, 2020, 40 (11) : 2744 - 2757
  • [26] THE ASSOCIATION OF UDCA TREATMENT WITH LONG-TERM OUTCOME AND BILIARY TRACT CANCER IN PATIENTS WITH PRIMARY SCLEROSING CHOLANGITIS
    Arizumi, Toshihiko
    Tazuma, Susumu
    Nakazawa, Takahiro
    Isayama, Hiroyuki
    Tsuyuguchi, Toshio
    Takikawa, Hajime
    Tanaka, Atsushi
    HEPATOLOGY, 2020, 72 : 74A - 75A
  • [27] EFFECT OF URSODEOXYCHOLIC ACID ON BILE-ACID METABOLISM IN PATIENTS WITH PRIMARY SCLEROSING CHOLANGITIS
    RUDOLPH, G
    STIEHL, A
    RAEDSCH, R
    WALKER, S
    HEPATOLOGY, 1990, 12 (02) : 439 - 439
  • [28] PRIMARY SCLEROSING CHOLANGITIS IN CHILDHOOD - INITIAL PRESENTATION, NATURAL HISTORY AND LONG-TERM OUTCOME
    Skarby, Anna Jerregard
    Casswall, Thomas
    Bergquist, Annika
    Lindstrom, Lina
    HEPATOLOGY, 2022, 76 : S1492 - S1492
  • [29] Ursodeoxycholic acid as a chemopreventive agent in patients with ulcerative colitis and primary sclerosing cholangitis
    Pardi, DS
    Loftus, EV
    Kremers, WK
    Keach, J
    Lindor, KD
    GASTROENTEROLOGY, 2003, 124 (04) : 889 - 893
  • [30] High-dose ursodeoxycholic acid as a therapy for patients with primary sclerosing cholangitis
    Harnois, DM
    Angulo, P
    Jorgensen, RA
    LaRusso, NF
    Lindor, KD
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2001, 96 (05): : 1558 - 1562
12345